All stock lists
Innospec Inc. (NASDAQ:IOSP)
US · Delayed Price · Currency is USD
Basic Materials · Chemicals - Specialty
$79.48+$0.37 (+0.47%)
Market cap
$1.96B
Insider Score
Health Score
Analyst consensus
Listed since
May 13, 1998
Website
Insider Score
75/ 100
IOSP Insider Score
Bullish1 qualifying trade · 1 insider · $27.49K bought in the last 90 days
Financial Health Score
Strong
From IOSP’s reported statements · Q3 2026 (trailing 12 months)
Profitability14 / 20
Profitable, but on a thin margin.
- Revenue
- $1.87B
- Net income
- $140.4M
- Net margin
- 7.5%
Leverage20 / 20
Little or no net debt.
- Total debt
- $47.3M
- Cash
- $251.9M
- Net debt / EBITDA
- -0.98x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $1.03B
- Current liabilities
- $351.2M
- Current ratio
- 2.95
Cash generation13 / 20
Roughly cash-neutral.
- Operating cash flow
- $103.6M
- Free cash flow
- $41.5M
- FCF margin
- 2.2%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 24.6M
- Share growth (1y)
- -0.8%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
IOSP Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $473.60 M | $491.40 M | $453.20 M | $455.60 M | $441.90 M | $439.70 M |
| Revenue Growth (YoY) | 7.17 % | 11.76 % | 2.81 % | -2.40 % | -0.34 % | 1.08 % |
| Cost of Revenue | $344.50 M | $353.10 M | $329.70 M | $328.20 M | $325.20 M | $316.50 M |
| Gross Profit | $129.10 M | $138.30 M | $123.50 M | $127.40 M | $116.70 M | $123.20 M |
| SG&A Expense | $71.70 M | $84.30 M | $78.50 M | $69.30 M | $71.90 M | $74.60 M |
| R&D Expense | $16.80 M | $14.20 M | $13.20 M | $11.00 M | $13.70 M | $13.60 M |
| Operating Expenses | $87.40 M | $98.60 M | $91.70 M | $80.30 M | $85.60 M | $88.90 M |
| Operating Income | $41.70 M | $39.70 M | $31.80 M | $47.10 M | $31.10 M | $34.30 M |
| Pretax Income | $42.60 M | $41.60 M | $39.90 M | $50.30 M | $11.50 M | $31.90 M |
| Tax Provision | $11.00 M | $10.40 M | $9.10 M | $2.90 M | -$1.40 M | $8.40 M |
| Net Income | $31.80 M | $30.80 M | $30.40 M | $47.40 M | $12.90 M | $23.50 M |
| EPS (Basic) | $1.29 | $1.25 | $1.23 | $1.91 | $0.52 | $0.94 |
| EPS (Diluted) | $1.29 | $1.25 | $1.22 | $1.91 | $0.52 | $0.94 |
| Shares Outstanding | 24.63 M | 24.64 M | 24.78 M | 24.78 M | 24.83 M | 24.94 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.